Physician profile
Janice Shaw
NPI 1639575350
$1,136.36
in general payments reported to CMS, 2019-2025
18 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $666 · 2022: $245 · 2023: $95.61 · 2024: $15.50 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $163.04 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $154.96 | 2021-2023 | Xarelto |
| Amgen INC. | $129.35 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.95 | 2021-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.65 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $72.92 | 2021-2023 | |
| Pfizer INC. | $69.79 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $58.63 | 2021-2025 | |
| United Therapeutics Corporation | $57.78 | 2021-2022 | |
| Abbott Laboratories | $48.87 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.69 | 2021-2022 | |
| Cvrx, INC. | $41.88 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.60 | 2021-2025 | Uptravi |
| Medtronic, INC. | $19.11 | 2025 | Linq II |
| Lantheus Medical Imaging, INC. | $18.61 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.73 | 2025 | Camzyos |
| Philips North America LLC | $15.50 | 2024 | (Cm9) Amb Mon & Diag Und |
| Boston Scientific Corporation | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.